Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections

Autor:	Epstein, Jay, Martin Smid, W., Wendel, Silvano, Somuah, Daniel, Burnouf, Thierry
Rok vydání:	2020
Předmět:	lcsh:Immunologic diseases. Allergy Pharmacology 2019-20 coronavirus outbreak Convalescent plasma Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Comment Immunology Diseases lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens lcsh:RC254-282 Medical research Infectious Diseases Risk factors Low and middle income countries Environmental health Medicine Pharmacology (medical) Human research lcsh:RC581-607 business
Zdroj:	npj Vaccines, Vol 5, Iss 1, Pp 1-2 (2020) NPJ Vaccines npj Vaccines
ISSN:	2059-0105
Popis:	Ethical principles should prevail in the collection, testing and use of COVID-19 convalescent plasma (CCP) for human research in low- and middle- income countries. To appropriately guarantee safety, only blood establishments that comply with recognized quality standards should collect CCP.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1115e9eb1eb793345255cee42a341b10 https://pubmed.ncbi.nlm.nih.gov/33298976 Zobrazit plný text záznamu